Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 9
2003 8
2004 8
2005 4
2006 12
2007 13
2008 18
2009 20
2010 19
2011 30
2012 25
2013 29
2014 32
2015 34
2016 15
2017 24
2018 21
2019 20
2020 20
2021 18
2022 15
2023 10
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

347 results

Results by year

Filters applied: . Clear all
Page 1
A comparative analysis of intravenous infusion methods for low-resource environments.
Tomobi O, Avoian S, Ekwere I, Waghmare S, Diaban F, Davis G, Sy Y, Ogbonna O, Streete K, Aryee E, Kulasingham V, Sampson JB. Tomobi O, et al. Among authors: sampson jb. Front Med (Lausanne). 2024 Feb 20;11:1326144. doi: 10.3389/fmed.2024.1326144. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38444409 Free PMC article.
Ventilator Training through International Telesimulation in Sierra Leone.
Tomobi O, Nelson-Williams H, Laytin A, Bob-Ray C, Ekwere I, Banks MC, David E, Samen CDK, Kanu JE, Sampson JB. Tomobi O, et al. Among authors: sampson jb. ATS Sch. 2023 Sep 6;4(4):502-516. doi: 10.34197/ats-scholar.2022-0084OC. eCollection 2023 Dec. ATS Sch. 2023. PMID: 38196674 Free PMC article.
CD8+ T cells maintain killing of MHC-I-negative tumor cells through the NKG2D-NKG2DL axis.
Lerner EC, Woroniecka KI, D'Anniballe VM, Wilkinson DS, Mohan AA, Lorrey SJ, Waibl-Polania J, Wachsmuth LP, Miggelbrink AM, Jackson JD, Cui X, Raj JA, Tomaszewski WH, Cook SL, Sampson JH, Patel AP, Khasraw M, Gunn MD, Fecci PE. Lerner EC, et al. Among authors: sampson jh. Nat Cancer. 2023 Sep;4(9):1258-1272. doi: 10.1038/s43018-023-00600-4. Epub 2023 Aug 3. Nat Cancer. 2023. PMID: 37537301 Free PMC article.
Novel Immunotherapeutic Approaches for the Treatment of Glioblastoma.
Zaidi SE, Moelker E, Singh K, Mohan A, Salgado MA, Essibayi MA, Hotchkiss K, Shen S, Lee W, Sampson J, Khasraw M. Zaidi SE, et al. Among authors: sampson j. BioDrugs. 2023 Jul;37(4):489-503. doi: 10.1007/s40259-023-00598-2. Epub 2023 May 31. BioDrugs. 2023. PMID: 37256535 Review.
Outcomes in Patients with Intact and Resected Brain Metastasis Treated with 5-Fraction Stereotactic Radiosurgery.
Carpenter DJ, Fairchild AT, Adamson JD, Fecci PE, Sampson JH, Herndon JE, Torok JA, Mullikin TC, Kim GJ, Reitman ZJ, Kirkpatrick JP, Floyd SR. Carpenter DJ, et al. Among authors: sampson jh. Adv Radiat Oncol. 2022 Dec 29;8(2):101166. doi: 10.1016/j.adro.2022.101166. eCollection 2023 Mar-Apr. Adv Radiat Oncol. 2022. PMID: 36845614 Free PMC article.
Targeting the IL4 receptor with MDNA55 in patients with recurrent glioblastoma: Results of a phase IIb trial.
Sampson JH, Singh Achrol A, Aghi MK, Bankiewicz K, Bexon M, Brem S, Brenner A, Chandhasin C, Chowdhary S, Coello M, Ellingson BM, Floyd JR, Han S, Kesari S, Mardor Y, Merchant F, Merchant N, Randazzo D, Vogelbaum M, Vrionis F, Wembacher-Schroeder E, Zabek M, Butowski N. Sampson JH, et al. Neuro Oncol. 2023 Jun 2;25(6):1085-1097. doi: 10.1093/neuonc/noac285. Neuro Oncol. 2023. PMID: 36640127 Free PMC article.
347 results